BR112012015384A2 - "compostos de fórmula (i), uso cosmético e uso de um composto" - Google Patents
"compostos de fórmula (i), uso cosmético e uso de um composto"Info
- Publication number
- BR112012015384A2 BR112012015384A2 BR112012015384A BR112012015384A BR112012015384A2 BR 112012015384 A2 BR112012015384 A2 BR 112012015384A2 BR 112012015384 A BR112012015384 A BR 112012015384A BR 112012015384 A BR112012015384 A BR 112012015384A BR 112012015384 A2 BR112012015384 A2 BR 112012015384A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- compound
- formula
- cosmetic
- cosmetic use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28215109P | 2009-12-23 | 2009-12-23 | |
| FR0959477A FR2954316B1 (fr) | 2009-12-23 | 2009-12-23 | Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique |
| PCT/FR2010/052874 WO2011077046A1 (fr) | 2009-12-23 | 2010-12-22 | Dérivés phénoliques, et leur utilisation pharmaceutique ou cosmétique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012015384A2 true BR112012015384A2 (pt) | 2017-04-25 |
Family
ID=43034202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012015384A BR112012015384A2 (pt) | 2009-12-23 | 2010-12-22 | "compostos de fórmula (i), uso cosmético e uso de um composto" |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20130178633A1 (pt) |
| EP (1) | EP2516400B1 (pt) |
| JP (1) | JP5712226B2 (pt) |
| KR (1) | KR101450187B1 (pt) |
| CN (1) | CN102892757B (pt) |
| AU (1) | AU2010334644B2 (pt) |
| BR (1) | BR112012015384A2 (pt) |
| CA (1) | CA2784841A1 (pt) |
| FR (1) | FR2954316B1 (pt) |
| MX (1) | MX2012007097A (pt) |
| RU (1) | RU2012131404A (pt) |
| WO (1) | WO2011077046A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2954315B1 (fr) * | 2009-12-23 | 2012-02-24 | Galderma Res & Dev | Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique |
| FR2982261B1 (fr) * | 2011-11-04 | 2014-06-13 | Galderma Res & Dev | Nouveaux amides, et leur utilisation pharmaceutique ou cosmetique |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1188154A (en) * | 1966-05-28 | 1970-04-15 | Egyt Gyogyszervegyeszeti Gyar | New Pyridine Derivatives and process for their preparation |
| US4578390A (en) * | 1981-12-14 | 1986-03-25 | Merck & Co., Inc. | Hydroxybenzylamino derivatives as anti-inflammatory agents |
| FR2693461B1 (fr) | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
| US7064124B2 (en) * | 2001-03-27 | 2006-06-20 | Daiichi Suntory Pharma Co., Ltd. | NF-κB inhibitor containing substituted benzoic acid derivative as active ingredient |
| DE20217957U1 (de) * | 2002-11-20 | 2003-02-20 | Wella Ag | In 2-Stellung substituierte Resorcin-Derivate enthaltende Färbemittel sowie neue Resorcin-Derivate |
| GB0324551D0 (en) * | 2003-10-21 | 2003-11-26 | Karobio Ab | Novel compounds |
| US20090196912A1 (en) | 2004-07-30 | 2009-08-06 | Gpc Botech Ag | Pyridinylamines |
| EP1746088A1 (en) * | 2005-07-15 | 2007-01-24 | Wella Aktiengesellschaft | 2-Amino-5-aminomethyl-phenol derivatives and agent for coloring keratin fibers comprising these derivatives |
-
2009
- 2009-12-23 FR FR0959477A patent/FR2954316B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-22 WO PCT/FR2010/052874 patent/WO2011077046A1/fr active Application Filing
- 2010-12-22 MX MX2012007097A patent/MX2012007097A/es not_active Application Discontinuation
- 2010-12-22 US US13/519,120 patent/US20130178633A1/en not_active Abandoned
- 2010-12-22 RU RU2012131404/04A patent/RU2012131404A/ru not_active Application Discontinuation
- 2010-12-22 KR KR1020127018959A patent/KR101450187B1/ko not_active IP Right Cessation
- 2010-12-22 CN CN201080059010.2A patent/CN102892757B/zh not_active Expired - Fee Related
- 2010-12-22 JP JP2012545397A patent/JP5712226B2/ja not_active Expired - Fee Related
- 2010-12-22 AU AU2010334644A patent/AU2010334644B2/en not_active Ceased
- 2010-12-22 EP EP10808918.6A patent/EP2516400B1/fr active Active
- 2010-12-22 CA CA2784841A patent/CA2784841A1/fr not_active Abandoned
- 2010-12-22 BR BR112012015384A patent/BR112012015384A2/pt not_active IP Right Cessation
-
2015
- 2015-07-27 US US14/809,815 patent/US10202346B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012131404A (ru) | 2014-02-10 |
| US10202346B2 (en) | 2019-02-12 |
| FR2954316A1 (fr) | 2011-06-24 |
| MX2012007097A (es) | 2012-07-20 |
| CN102892757A (zh) | 2013-01-23 |
| WO2011077046A1 (fr) | 2011-06-30 |
| US20160068488A1 (en) | 2016-03-10 |
| EP2516400A1 (fr) | 2012-10-31 |
| KR101450187B1 (ko) | 2014-10-14 |
| EP2516400B1 (fr) | 2017-03-22 |
| CA2784841A1 (fr) | 2011-06-30 |
| KR20120096095A (ko) | 2012-08-29 |
| US20130178633A1 (en) | 2013-07-11 |
| JP5712226B2 (ja) | 2015-05-07 |
| AU2010334644B2 (en) | 2014-07-17 |
| AU2010334644A1 (en) | 2012-08-09 |
| JP2013515707A (ja) | 2013-05-09 |
| FR2954316B1 (fr) | 2014-01-03 |
| CN102892757B (zh) | 2015-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012015366A2 (pt) | compostos de fórmula (i), uso cosmético e uso de um composto | |
| BR112012015392A2 (pt) | "composto e uso cosmético de um composto" | |
| BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
| BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0906186A2 (pt) | composto e uso de um composto | |
| BRPI0915134A2 (pt) | composto, e, uso de um composto | |
| BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
| SMT201400055B (it) | Composti di tioacetato, composizioni e metodi d'uso | |
| BRPI0911688A2 (pt) | "compostos de pirimidina, composições e métodos de uso" | |
| BR112013008259A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0810161A2 (pt) | Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto | |
| BR112013015397A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
| BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0812942A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
| BRPI0919165A2 (pt) | composição farmacêutica,e, uso de um composto | |
| BRPI0915473A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI1007017A2 (pt) | uso de um composto. | |
| BRPI0814304A2 (pt) | Uso de um composto metálico misto | |
| BRPI0916480A2 (pt) | composto de fórmula geral (i) e uso de pelo menos um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15I | Others concerning applications: loss of priority | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |